Skip to content
JournalsWorldThe Global Research Discovery Platform

Academic Journal

Q2

CNS and Neurological Disorders – Drug Targets

United Arab EmiratesMedicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)ISSN-matched source record
Q2Ranking
—Impact Factor (year unverified)
105H-index (SCImago 2025)
0.789SJR (2025)
2006-2026Coverage

About CNS and Neurological Disorders – Drug Targets

CNS and Neurological Disorders - Drug Targets is a scholarly journal published by Bentham Science Publishers. SCImago 2025 lists it in Q2, with an SJR of 0.789 and H-index of 105.

Coverage: 2006-2026. Research categories: Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2).

Source-backed journal facts

ISSN(s)1568-007X, 1871-5273, 1996-3181, 2212-5299
ISSN-L1568-007X
Source typeJournal
Publisher / hosting organisationBentham Science Publishers
Publisher country codeAE
Fully open access (OpenAlex)Not marked as fully open access; hybrid options may exist
DOAJ flag (OpenAlex)Not listed in OpenAlex metadata; this is not a direct DOAJ check
Works recorded in OpenAlex2,488
Citations recorded in OpenAlex69,345
OpenAlex H-index115
Years represented in OpenAlex1969–2026 (not the founding or closing dates)

Topics in published research

Alzheimer's disease research and treatments; Tryptophan and brain disorders; Cholinesterase and Neurodegenerative Diseases; Neuroscience and Neuropharmacology Research; Neuroinflammation and Neurodegeneration Mechanisms; Parkinson's Disease Mechanisms and Treatments.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit